Cite

HARVARD Citation

    Castiglione, J. et al. (2022). Long-Term Remission With Low-Dose Rituximab in Myasthenia Gravis: A Retrospective Study. Journal of clinical neuromuscular disease. 24 (1), pp. 18-25. [Online]. 
  
Back to record